Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
Spectrum Pharmaceuticals, Inc. announced today financial results for the three-month period and full year ended December 31, 2022.
Uncategorized
¿Cuántas toneladas de hielo se han derretido ya en la Antártida?
El calentamiento global avanza con fuerza, y ahora unos científicos han logrado calcular cuánto hielo neto se ha perdido en años recientes en la zona de la Antártida que más deprisa está cambiando. Una veintena de grandes glaciares conforman lo que …
¿Cuántas toneladas de hielo se han derretido ya en la Antártida? Read More »
La mejor dieta para luchar contra el calentamiento global
Suele darse valor a una dieta en función de cuánto contribuye a proteger la salud. Pero en una nueva investigación se ha examinado la cuestión desde la perspectiva de cuánto gas con efecto invernadero acarrea seguir cada dieta, teniendo en cuenta el proceso que sig …
La mejor dieta para luchar contra el calentamiento global Read More »
El Mal de Alzheimer acecha en los ojos
En este Short veremos cómo es posible descubrir síntomas del Mal de Alzheimer a través de los ojos. …
Planificando la exploración robótica de cuevas marcianas
En vez de construir en Marte desde cero un edificio que sirva de base habitable, aprovechar cavernas, así como de tubos de lava, sería una opción mucho mejor, para reducir el trabajo y el gasto de materiales de construcción, y en muchos casos para disponer de protecci&oac …
Planificando la exploración robótica de cuevas marcianas Read More »
Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases
Invitae (NYSE: NVTA), a leading medical genetics company, and Deerfield Management Company today announced a partnership to advance genetics-based drug discovery and development in rare disease.
Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases Read More »
Sage Therapeutics to Present at the Stifel 2023 CNS Days
Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced that the Company will present at the Stifel 2023 CNS Days on Wednesday, March 29, 2023, at 11:00 a.m. ET.
Sage Therapeutics to Present at the Stifel 2023 CNS Days Read More »
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics Inc. announced a $123 million Series B financing co-led by GordonMD® Global Investments LP and Pfizer Ventures, with participation from existing investors Boxer Capital, Casdin Capital, Eventide Asset Management, Invus Financial Advisors, Nextech Invest and Third Rock Ventures and new investors Agent Capital, Eli Lilly and Company, Memorial Sloan Kettering Cancer Center, Novartis,
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing Read More »
Alzheon to Present Biomarker, Brain Preservation and Clinical Effects of Oral Tablet ALZ-801 (Valiltramiprosate) at Upcoming AD/PD 2023 Conference in Gothenburg, Sweden
Alzheon, Inc. announced that it will be presenting interim findings from an ongoing Phase 2 study evaluating ALZ-801 tablet at the upcoming AD/PD 2023 Conference to be held from March 28 – April 1, 2023 in Gothenburg, Sweden.
TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China
TaiGen Biotechnology Company, Limited announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical Group Industry Co., Ltd., a top 10 China pharmaceutical company, to develop and commercialize TG-1000 in China.
TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China Read More »